Your browser doesn't support javascript.
loading
CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies.
Mi, Jian-Qing; Xu, Jie; Zhou, Jianfeng; Zhao, Weili; Chen, Zhu; Melenhorst, J Joseph; Chen, Saijuan.
Afiliação
  • Mi JQ; State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, National Research Centre for Translational Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Xu J; State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, National Research Centre for Translational Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Zhou J; Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
  • Zhao W; Immunotherapy Research Centre for Hematologic Diseases of Hubei Province, Department of Haematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Chen Z; State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, National Research Centre for Translational Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Melenhorst JJ; State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, National Research Centre for Translational Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Chen S; Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. jos.melenhorst@pennmedicine.upenn.edu.
Front Med ; 15(6): 783-804, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34921673

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Receptores de Antígenos Quiméricos / Neoplasias Limite: Humans Idioma: En Revista: Front Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Receptores de Antígenos Quiméricos / Neoplasias Limite: Humans Idioma: En Revista: Front Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China